US market expansion Calcivis has established a US headquarters in Milton, Massachusetts and is actively expanding its US commercial team, signaling a strategic focus on entering and scaling within the American dental market.

FDA approval leverage With FDA clearance in hand, Calcivis is well positioned to approach US clinicians for real-time caries assessment solutions, offering a differentiator in preventive dentistry and potential to upsell to practices seeking minimally invasive, chairside imaging.

Key leadership depth Recent appointments of non-executive directors and senior sales, marketing, and financial executives strengthen governance and go-to-market execution, enabling more effective US and global commercialization and partner engagements.

Strategic partnerships Healthcare and investment backing, including involvement from the Scottish National Investment Bank, enhances credibility for hospital/specialty dental networks and could open doors for pilot programs, strategic collaborations, and distribution deals.

Preventive dentistry focus The technology enables early decision-making and improved patient communication, creating opportunities to position Calcivis with dental practices pursuing preventive care programs, patient engagement tools, and recurring imaging-based services.